Actively Recruiting
The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia
Led by University of Oxford · Updated on 2026-03-12
142
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
Sponsors
U
University of Oxford
Lead Sponsor
O
Oxford University Hospitals NHS Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if a digital sleep therapy program (digital Cognitive Behavioural Therapy for Insomnia or dCBT-I) works to improve quality of life and movement in adults with fibromyalgia who also have trouble sleeping. The main questions it aims to answer are: * Does digital sleep therapy improve quality of life for people with fibromyalgia? * Does digital sleep therapy improve sleep quality? * Does better sleep help reduce fear of movement and increase physical activity, assessed in a virtual reality (VR) environment? Researchers will compare digital sleep therapy (called 'Sleepio') to standard care with sleep advice materials. Participants will: * Use the Sleepio program at home for 10 weeks (6 sessions, 20 minutes each) * Wear a sleep monitoring device at home in bed for several nights at the start and after 3 months * Wear an activity watch for 1 week to track movement at the start and after 3 months * Complete questionnaires about pain, sleep, mood, and daily activities at the start, 3 months, and 6 months * Visit the study centre twice for assessments that include: * Pain sensitivity testing * A virtual reality game that measures how they move and make decisions * Recording of simple exercises like marching and squats Participation in the study lasts about 6 months.
CONDITIONS
Official Title
The Effect of Digital Cognitive Behavioural Therapy for Insomnia on Physical Activity in Fibromyalgia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willing and able to provide informed consent for participation in the study
- Male or female, aged 18 years or above
- Clinical diagnosis of fibromyalgia or chronic widespread pain
- Concomitant insomnia, frequent nighttime waking, or early morning waking
- Self-reported difficulties with concentration or memory
- Reliable internet access (required to access digital intervention)
You will not qualify if you...
- Poor understanding of English
- Known neurological conditions (other than depression or anxiety) likely to independently affect pain assessment results (e.g., peripheral diabetic neuropathy)
- Major neuropsychiatric disorder (bipolar disorder, schizophrenia, or psychotic spectrum disorders)
- Epilepsy
- Cognitive impairment, dementia, or neurodegenerative disorder
- Recent surgery (within past 3 months) or planned surgery during study period
- Current night-time shift work or planned night-time shift work during study period
- Diagnosed sleep disorders including sleep apnea, restless leg syndrome, circadian rhythm disorder, or parasomnia
- Taking prescribed sleep medications on more than 2 nights in the past 2 weeks
- Currently receiving other psychological therapy for insomnia
- Pregnant or lactating
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Oxford Centre for Integrative Neuroimaging
Oxford, United Kingdom, OX3 9DU
Not Yet Recruiting
2
University of Oxford
Oxford, United Kingdom, OX3 9DU
Actively Recruiting
Research Team
A
Amanda Wall, BSc MSc
CONTACT
E
Eoin Kelleher, MB BCh DPhil
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here